Mallinckrodt initiates rolling submission of biologics license application for stratagraft regenerative skin tissue to u.s. fda

Mallinckrodt initiates rolling submission of biologics license application for stratagraft® regenerative skin tissue to u.s. food and drug administration.mallinckrodt plc - expects to complete submission of bla for stratagraft in coming months.
MNK Ratings Summary
MNK Quant Ranking